Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 31.75
+0.05 (0.16%)
Jan 22, 2026, 10:39 AM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.44 billion as of January 21, 2026. Its market cap has increased by 0.63% in one year.
Market Cap
4.44B
Enterprise Value
6.26B
Revenue
1.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
31.75
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.44B, an increase of 549.16%. That is a compound annual growth rate of 9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.53B | 0.31% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 5.46B |
| UnicoCell Biomed | 5.24B |
| AnnJi Pharmaceutical | 4.83B |
| BioGend Therapeutics | 4.71B |
| Formosa Pharmaceuticals | 4.52B |
| Senhwa Biosciences | 4.10B |
| Energenesis Biomedical CO.,LTD. | 4.02B |
| ACRO Biomedical | 3.80B |